Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
26.45
-0.40 (-1.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 1,304 | 710 | - |
| Enterprise Value | 969 | 512 | - |
| Last Close Price | 26.45 | 15.43 | - |
| PB Ratio | 3.92 | 2.13 | - |
| P/TBV Ratio | 3.92 | 2.13 | - |
| Debt / Equity Ratio | 0.00 | 0.00 | -2.30 |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -0.82 |
| Net Debt / EBITDA Ratio | 2.95 | 2.95 | - |
| Net Debt / FCF Ratio | 3.53 | 3.53 | -0.84 |
| Quick Ratio | 20.33 | 20.33 | 5.78 |
| Current Ratio | 21.09 | 21.09 | 5.81 |
| Return on Equity (ROE) | -89.19% | -89.19% | - |
| Return on Assets (ROA) | -33.59% | -33.59% | - |
| Return on Capital Employed (ROCE) | -34.10% | -34.10% | -106.00% |
| Earnings Yield | -7.68% | -17.95% | - |
| FCF Yield | -7.27% | -13.37% | - |
| Buyback Yield / Dilution | - | -893.82% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.